Twelve percent of American adults are on a GLP-1 receptor agonist as of KFF's most recent survey, double the share from May 2024. [1] Sixty percent of U.S. consumers told a Franchise Times survey on April 29 that they would order smaller, protein-forward meals if offered. Thirty-seven percent told the same survey they specifically did not want those meals labeled "GLP-1 friendly." [2] The post-Ozempic restaurant grammar — protein-forward, fiber-rich, smaller portions, lower added sugar — is being printed on national-chain menu inserts this spring. The label that goes on the menu insert is what's contested.

Smoothie King published the GLP-1 vocabulary in October 2024, when it became the first national QSR brand to launch a "GLP-1 Support Menu" by name. The chain's five smoothies — Gladiator GLP-1, Slim N Trim GLP-1 Mango Greens, Keto Champ GLP-1 (berry or chocolate), the Activator Recovery GLP-1 Almond Berry and Power Meal Slim GLP-1 — carry 19 to 61 grams of protein, 2 to 15 grams of fiber and zero added sugar. [3] The menu was developed with registered dietitian Molly Kimball of Ochsner Health's Eat Fit program. CEO Wan Kim said in the launch release that "with the rising use of GLP-1s, we want to be there for our guests." Smoothie King's nearly 1,200 U.S. locations carry the menu in-store and online. [4]

Olive Garden took the opposite naming approach. The Darden-owned chain announced in December 2025 a "Lighter Portions" section, seven dishes at smaller portion sizes and lower prices. [5] CEO Ricardo Cardenas told the December earnings call the menu was "designed to give guests more choices" and "just so happens to benefit the consumers that might want smaller portions that are on GLP-1 medications." The arithmetic on the menu insert is what reveals the design: an Olive Garden chicken parmigiana is 1,020 calories and 64 grams of protein in the regular portion; the lighter-portion counterpart is 630 calories and 36 grams of protein — a 38 percent calorie cut and a 44 percent protein cut at the same dish-name SKU. [5] The customer who orders the lighter portion gets dietary architecture suited to a GLP-1 user. The menu insert does not say so.

The paper's reading is that this is not a labeling fight, it is a marketing one. Forty-five percent of GLP-1 users in the Franchise Times sample report eating out two to three times a week, the same rate as the general population — but they spend an average of 12 percent less per visit. [2] A chain that wins the protein-forward, fiber-rich, smaller-portion architecture without naming GLP-1s captures both the medication user and the 37 percent of all consumers who do not want to be marketed-to as medication users. Olive Garden's "Lighter Portions" framing performs that capture by design. Smoothie King's "GLP-1 Support" framing converts a smaller customer base into a higher-margin, premium-positioned visit — the Gladiator GLP-1's protein content is competitive with a steak entrée at twice the calorie load. [6]

Subway's $3.99 Protein Pockets, launched January 2026, follow the unlabeled approach. Chipotle now offers a high-protein menu with a 32-gram cubed-chicken option priced "around the cost of a latte." [7] Shake Shack's "Good Fit Menu" offers lettuce-wrapped versions of the chain's smash burgers — 4 grams of carbohydrate per burger, no bun, the protein content of the standard SKU. [7] Sweetgreen and Cava have repositioned bowl architecture toward 35-50 gram protein totals at lunch. McDonald's has not yet adopted the GLP-1 framing in customer-facing language, even as the chain has introduced higher-protein limited-time offers under different marketing copy.

Cuba Libre Restaurant and Rum Bar, a Philadelphia and Atlantic City independent group, ran an early-March 2026 menu pilot in which servers offered a printed insert specifically labeled for GLP-1 users at the start of the meal — protein-forward, fiber-rich, half-portion entrees, with sodium and sugar reduced. The pilot generated AP photo-wire coverage that reached Fortune. [8] The independent-restaurant data is partial and self-selected, but the operative data point is that customers who self-identified as GLP-1 users on the pilot ordered the inserted items at a higher rate than the regular menu. The labeling did not deter them.

For consumers walking into a national chain this week, the practical reading: the menu they are staring at is being designed for someone else. The chain has not necessarily told them that. The 37 percent who do not want a "GLP-1 friendly" label are being marketed-to in language designed to slip past the label. The 12 percent on the medication are being marketed-to in language designed to land. The 51 percent who fall into neither category are being given protein-forward, smaller-portion options that match general dietary advice for adults — fiber, lean protein, lower added sugar — but that emerged in chain restaurants because of the medication, not the advice. [1] [9]

The trend's commercial logic is that a chain capturing the GLP-1 user without naming them captures all three customer segments at once. The clinical logic is that high-protein, high-fiber, lower-added-sugar food architecture is net-positive for everyone — what dietitians have recommended for decades. The Smoothie King Gladiator GLP-1 is named for its medication user. The Olive Garden Lighter Portions chicken parmigiana is named for the dish.

Novo Nordisk, the maker of Ozempic and Wegovy, did not respond to NBC's January 2026 request for comment on whether it markets to restaurants directly. [9] Eli Lilly has funded GLP-1 dietary research separately. The pharmaceutical industry has not entered the restaurant-marketing conversation publicly. The retail industry has done the work without the partnership. The paper's framing has held: the restaurant industry is reorganizing around pharmaceutical-induced appetite shrinkage, and consciously hiding it from 37 percent of the customers it serves. [2]

The next watch is at the menu-insert layer. If Cracker Barrel, Outback, Denny's or Chili's add GLP-1-friendly architecture under non-GLP-1 names, the trend has captured casual dining. The clinical conversation focuses on prescribers and insurance. The cultural conversation, in 2026, runs through the menu insert.

-- NORA WHITFIELD, Chicago